China's central government spent Yuan116.2 billion ($17.1 billion) on measures to support reforms to the national pharmaceutical and healthcare system in 2009, and is gearing up for further changes this year, including the full adoption of new ...
Latvia's second-largest pharmaceutical manufacturer Olainfarm is to open a representative office in Bangkok, Thailand, to maintain sales growth in Asia and diversify risks.
Its chairman
Valerijs Maligins
said that the opening of the new office, ...
Dynavax Technologies ' future could be under threat after its cash and cash equivalents fell by $9.7 million to $36.7 million at the end of last year.
The infectious disease-focused biopharmaceutical company's independent accounting firm questioned ...
AstraZeneca has hastily rewritten expectations for its business in emerging markets, an area of key growth if it is to prosper after several key products lose patent protection in its core markets.
In little over a month, the UK firm has scaled back ...
OSI Pharmaceuticals ' board has unanimously rejected Astellas 's unsolicited $52 per share cash offer for the company, recommending that OSI shareholders do the same.
After a formal review, which included external advisors, the board's conclusion ...
